ORIGINAL RESEARCH
Published on 29 May 2025
Polypharmacy, drug–drug interactions and adverse drug reactions in older Chinese cancer patients: evidence from CHARLS
doi 10.3389/fphar.2025.1579023
- 256 views
- Frontiers in Pharmacology
- Pharmacology of Anti-Cancer Drugs
- Research Topics
- Evidence-Based Research and Clinical Application of Adverse Reactions and Management Strategies for Cancer Treatment Drugs
Evidence-Based Research and Clinical Application of Adverse Reactions and Management Strategies for Cancer Treatment Drugs
468
Total downloads
4,359
Total views and downloads
Submit your idea
Select the journal/section where you want your idea to be submitted:
Articles
CASE REPORT
Accepted on 19 May 2025
Case report: Osimertinib-induced acute interstitial lung disease
doi 10.3389/fphar.2025.1608733
ORIGINAL RESEARCH
Published on 16 May 2025
Cyclophosphamide for anticancer therapy-induced interstitial lung disease in the modern era: a retrospective cohort study
doi 10.3389/fonc.2025.1567317
- 508 views
ORIGINAL RESEARCH
Published on 30 Apr 2025
Analysis of three treatment methods for granulomatous lobular mastitis: a retrospective study in a single center
doi 10.3389/fonc.2025.1588836
- 618 views
ORIGINAL RESEARCH
Published on 08 Apr 2025
Efficacy and safety of pyrotinib in the treatment of HER2-positive liver metastatic advanced breast cancer
doi 10.3389/fonc.2025.1527277
- 572 views
Published in
Frontiers in Pharmacology
Pharmacology of Anti-Cancer Drugs
Pharmacoepidemiology
Participating Journals
Frontiers in Oncology
- 3.5 impact factor
- 6.2 citescore
Manuscripts can be submitted to this Research Topic via the main journal or any other participating journal.
Submit your idea
Select the journal/section where you want your idea to be submitted: